n-Fmoc-5,5-dimethyl-L-norleucine is a sterically enhanced aliphatic amino acid featuring terminal dimethyl substitution. The added bulk influences backbone orientation and hydrophobic packing in synthetic peptides. Researchers employ it to study steric constraints, helix modulation, and solvent-dependent conformations. Its Fmoc protection supports compatibility with standard solid-phase methods.
CAT No: R2141
CAS No:1217704-60-3
Synonyms/Alias:n-fmoc-5,5-dimethyl-l-norleucine;1217704-60-3;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5,5-dimethylhexanoic acid;(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-5,5-dimethylhexanoic acid;MFCD30533759;CS-0104683;D76435;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-5,5-dimethylhexanoic acid;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More